Literature DB >> 11819756

Transjugular portosystemic stent shunt in treatment of liver diseases.

M Schepke1, T Sauerbruch.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11819756      PMCID: PMC4723518          DOI: 10.3748/wjg.v7.i2.170

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  36 in total

1.  Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.

Authors:  G V Papatheodoridis; J Goulis; G Leandro; D Patch; A K Burroughs
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

2.  Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.

Authors:  L García-Villarreal; F Martínez-Lagares; A Sierra; C Guevara; J M Marrero; E Jiménez; A Monescillo; T Hernández-Cabrero; J M Alonso; R Fuentes
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

3.  Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.

Authors:  M Rössle; P Deibert; K Haag; A Ochs; M Olschewski; V Siegerstetter; K H Hauenstein; R Geiger; C Stiepak; W Keller; H E Blum
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

4.  Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis.

Authors:  L Laine; D Cook
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

5.  Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.

Authors:  J Quiroga; B Sangro; M Núñez; I Bilbao; J Longo; L García-Villarreal; J M Zozaya; M Betés; J I Herrero; J Prieto
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

6.  Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial.

Authors:  A J Sanyal; A M Freedman; V A Luketic; P P Purdum; M L Shiffman; P E Cole; J Tisnado; S Simmons
Journal:  Ann Intern Med       Date:  1997-06-01       Impact factor: 25.391

7.  Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial.

Authors:  J P Cello; E J Ring; E W Olcott; J Koch; R Gordon; J Sandhu; D R Morgan; J W Ostroff; D C Rockey; P Bacchetti; J LaBerge; J R Lake; K Somberg; C Doherty; M Davila; K McQuaid; S D Wall
Journal:  Ann Intern Med       Date:  1997-06-01       Impact factor: 25.391

8.  Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis.

Authors:  P S Kamath; M Lacerda; D A Ahlquist; M A McKusick; J C Andrews; D A Nagorney
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

9.  The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.

Authors:  A Ochs; M Rössle; K Haag; K H Hauenstein; P Deibert; V Siegerstetter; M Huonker; M Langer; H E Blum
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

10.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.

Authors:  J Cabrera; M Maynar; R Granados; E Gorriz; R Reyes; J M Pulido-Duque; J L Rodriguez SanRoman; C Guerra; D Kravetz
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

View more
  4 in total

Review 1.  Current use of transjugular intrahepatic portosystemic shunts.

Authors:  Timothy M McCashland
Journal:  Curr Gastroenterol Rep       Date:  2003-02

2.  Direct intrahepatic portacaval shunt: an experimental study.

Authors:  Jian-Jun Luo; Zhi-Ping Yan; Kang-Rong Zhou; Sheng Qian
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Budd-Chiari syndrome: diagnosis with three-dimensional contrast-enhanced magnetic resonance angiography.

Authors:  Jiang Lin; Xiao-Hai Chen; Kang-Rong Zhou; Zu-Wang Chen; Jian-Hua Wang; Zhi-Ping Yan; Ping Wang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

4.  Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis.

Authors:  Zai-Bo Jiang; Hong Shan; Xin-Ying Shen; Ming-Sheng Huang; Zheng-Ran Li; Kang-Shun Zhu; Shou-Hai Guan
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.